By Friedrich Geiger

BERLIN--Fresenius SE (FRE.XE) Thursday raised the lower end of its full-year earnings guidance after each of the healthcare company's segments grew organically in every region in the third quarter.

Adjusted for currency changes, Fresenius SE now expects net profit to be 12% to 14% higher than last year's adjusted net profit. The company had earlier forecast an increase of at least 11%. In the third quarter, Fresenius SE's net profit grew 12% to 399 million euros ($435 million), nearly in line with analysts' EUR402 million average estimate. Revenue rose 6% to EUR7.34 billion.

Fresenius Medical Care, the ​dialysis provider in which Fresenius SE holds a stake, also released results showing third-quarter net profit up 27% at $333 million, compared with analysts' $324 million consensus estimate. Revenue grew 9% to $4.60 billion. Fresenius Medical Care confirmed its full-year guidance.

Write to Friedrich Geiger at friedrich.geiger@wsj.com

(END) Dow Jones Newswires

October 27, 2016 01:43 ET (05:43 GMT)

Copyright (c) 2016 Dow Jones & Company, Inc.
Fresenius Medical Care (NYSE:FMS)
Historical Stock Chart
From Aug 2024 to Sep 2024 Click Here for more Fresenius Medical Care Charts.
Fresenius Medical Care (NYSE:FMS)
Historical Stock Chart
From Sep 2023 to Sep 2024 Click Here for more Fresenius Medical Care Charts.